Nasopharyngeal carcinoma distant metastasis risk prediction method and system based on cross-modal Transform and depth consistency loss
The method of predicting distant metastasis risk of nasopharyngeal carcinoma using cross-modal Transformer and depth consistency loss solves the problems of insufficient utilization of multimodal imaging information and risk ranking, achieves more accurate risk assessment and early identification of high-risk patients, and enhances the clinical application value of the prediction model.
Patent Information
- Application Number
- CN202610351328.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-03-21
- Publication Date
- 2026-07-24
AI Technical Summary
Existing methods for predicting the risk of distant metastasis in nasopharyngeal carcinoma cannot fully utilize multimodal MRI image information, cannot effectively model the deep nonlinear interaction between clinical variables and imaging features, and are difficult to perform risk ranking learning on censored survival data, resulting in insufficient prediction accuracy and early identification of high-risk patients.
We employ a method based on cross-modal Transformer and depth consistency loss to construct a nasopharyngeal carcinoma distant metastasis risk prediction model by fusing multimodal MRI images and structured clinical data, utilizing cross-modal cross-attention mechanism for feature fusion, and combining depth consistency loss for risk ranking optimization.
It improved the accuracy and stability of predicting the risk of distant metastasis in nasopharyngeal carcinoma, enhanced the ability to identify high-risk patients, especially those with early distant metastasis, and improved the model's ranking ability in survival analysis.